Go Pro

iHuman (IH) Competitors

iHuman logo
$1.42 +0.01 (+0.35%)
Closing price 07/13/2026 03:55 PM Eastern
Extended Trading
$1.42 0.00 (0.00%)
As of 07/13/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

IH vs. JDZG, TONX, NRDY, HCMA, and HERE

Should you buy iHuman stock or one of its competitors? MarketBeat compares iHuman with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with iHuman include JIADE (JDZG), Verb Technology (TONX), Nerdy (NRDY), HCM Acquisition (HCMA), and Quantasing Group (HERE). These companies are all part of the "personal services" industry.

How does iHuman compare to JIADE?

JIADE (NASDAQ:JDZG) and iHuman (NYSE:IH) are both small-cap consumer discretionary companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, media sentiment, profitability and valuation.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
JIADE
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
iHuman
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

iHuman has higher revenue and earnings than JIADE.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
JIADE$3.67M73.98-$1.51MN/AN/A
iHuman$115.40M0.63$13.64M$0.197.50

4.9% of iHuman shares are owned by institutional investors. 63.6% of iHuman shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

JIADE has a beta of 2, meaning that its stock price is 100% more volatile than the broader market. Comparatively, iHuman has a beta of 0.15, meaning that its stock price is 85% less volatile than the broader market.

iHuman has a net margin of 9.35% compared to JIADE's net margin of 0.00%. iHuman's return on equity of 7.46% beat JIADE's return on equity.

Company Net Margins Return on Equity Return on Assets
JIADEN/A N/A N/A
iHuman 9.35%7.46%5.40%

In the previous week, JIADE had 3 more articles in the media than iHuman. MarketBeat recorded 3 mentions for JIADE and 0 mentions for iHuman. JIADE's average media sentiment score of 0.48 beat iHuman's score of 0.00 indicating that JIADE is being referred to more favorably in the media.

Company Overall Sentiment
JIADE Neutral
iHuman Neutral

Summary

iHuman beats JIADE on 7 of the 11 factors compared between the two stocks.

How does iHuman compare to Verb Technology?

iHuman (NYSE:IH) and Verb Technology (NASDAQ:TONX) are both small-cap personal services companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, media sentiment, dividends, analyst recommendations, valuation, risk and profitability.

iHuman has a beta of 0.15, indicating that its stock price is 85% less volatile than the broader market. Comparatively, Verb Technology has a beta of 0.73, indicating that its stock price is 27% less volatile than the broader market.

iHuman has higher revenue and earnings than Verb Technology. Verb Technology is trading at a lower price-to-earnings ratio than iHuman, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
iHuman$115.40M0.63$13.64M$0.197.50
Verb Technology$12.78M14.69-$148.48M-$2.84N/A

iHuman has a net margin of 9.35% compared to Verb Technology's net margin of -1,416.59%. iHuman's return on equity of 7.46% beat Verb Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
iHuman9.35% 7.46% 5.40%
Verb Technology -1,416.59%-78.40%-76.10%

In the previous week, Verb Technology had 1 more articles in the media than iHuman. MarketBeat recorded 1 mentions for Verb Technology and 0 mentions for iHuman. Verb Technology's average media sentiment score of 1.87 beat iHuman's score of 0.00 indicating that Verb Technology is being referred to more favorably in the news media.

Company Overall Sentiment
iHuman Neutral
Verb Technology Very Positive

4.9% of iHuman shares are owned by institutional investors. Comparatively, 7.2% of Verb Technology shares are owned by institutional investors. 63.6% of iHuman shares are owned by insiders. Comparatively, 21.4% of Verb Technology shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
iHuman
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Verb Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

iHuman beats Verb Technology on 8 of the 13 factors compared between the two stocks.

How does iHuman compare to Nerdy?

Nerdy (NYSE:NRDY) and iHuman (NYSE:IH) are both small-cap consumer discretionary companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, media sentiment, analyst recommendations, institutional ownership and profitability.

In the previous week, Nerdy had 2 more articles in the media than iHuman. MarketBeat recorded 2 mentions for Nerdy and 0 mentions for iHuman. Nerdy's average media sentiment score of 0.40 beat iHuman's score of 0.00 indicating that Nerdy is being referred to more favorably in the media.

Company Overall Sentiment
Nerdy Neutral
iHuman Neutral

iHuman has a net margin of 9.35% compared to Nerdy's net margin of -18.60%. iHuman's return on equity of 7.46% beat Nerdy's return on equity.

Company Net Margins Return on Equity Return on Assets
Nerdy-18.60% -93.27% -45.70%
iHuman 9.35%7.46%5.40%

iHuman has lower revenue, but higher earnings than Nerdy. Nerdy is trading at a lower price-to-earnings ratio than iHuman, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nerdy$178.99M0.96-$39.92M-$0.28N/A
iHuman$115.40M0.63$13.64M$0.197.50

39.1% of Nerdy shares are held by institutional investors. Comparatively, 4.9% of iHuman shares are held by institutional investors. 51.5% of Nerdy shares are held by company insiders. Comparatively, 63.6% of iHuman shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Nerdy currently has a consensus price target of $1.00, indicating a potential upside of 10.86%. Given Nerdy's stronger consensus rating and higher probable upside, analysts plainly believe Nerdy is more favorable than iHuman.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nerdy
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
iHuman
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Nerdy has a beta of 1.73, meaning that its share price is 73% more volatile than the broader market. Comparatively, iHuman has a beta of 0.15, meaning that its share price is 85% less volatile than the broader market.

Summary

Nerdy beats iHuman on 8 of the 15 factors compared between the two stocks.

How does iHuman compare to HCM Acquisition?

HCM Acquisition (NASDAQ:HCMA) and iHuman (NYSE:IH) are both small-cap personal services companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, dividends, risk, profitability, earnings and media sentiment.

11.8% of HCM Acquisition shares are owned by institutional investors. Comparatively, 4.9% of iHuman shares are owned by institutional investors. 71.2% of HCM Acquisition shares are owned by insiders. Comparatively, 63.6% of iHuman shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

iHuman has a net margin of 9.35% compared to HCM Acquisition's net margin of 0.00%. iHuman's return on equity of 7.46% beat HCM Acquisition's return on equity.

Company Net Margins Return on Equity Return on Assets
HCM AcquisitionN/A N/A N/A
iHuman 9.35%7.46%5.40%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
HCM Acquisition
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
iHuman
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

iHuman has higher revenue and earnings than HCM Acquisition.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HCM AcquisitionN/AN/AN/AN/AN/A
iHuman$115.40M0.63$13.64M$0.197.50

HCM Acquisition has a beta of -0.27, meaning that its share price is 127% less volatile than the broader market. Comparatively, iHuman has a beta of 0.15, meaning that its share price is 85% less volatile than the broader market.

In the previous week, HCM Acquisition had 3 more articles in the media than iHuman. MarketBeat recorded 3 mentions for HCM Acquisition and 0 mentions for iHuman. HCM Acquisition's average media sentiment score of 1.57 beat iHuman's score of 0.00 indicating that HCM Acquisition is being referred to more favorably in the media.

Company Overall Sentiment
HCM Acquisition Very Positive
iHuman Neutral

Summary

iHuman beats HCM Acquisition on 5 of the 9 factors compared between the two stocks.

How does iHuman compare to Quantasing Group?

iHuman (NYSE:IH) and Quantasing Group (NASDAQ:HERE) are both small-cap personal services companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, analyst recommendations, valuation, profitability, earnings, dividends and media sentiment.

4.9% of iHuman shares are owned by institutional investors. 63.6% of iHuman shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Quantasing Group has higher revenue and earnings than iHuman. Quantasing Group is trading at a lower price-to-earnings ratio than iHuman, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
iHuman$115.40M0.63$13.64M$0.197.50
Quantasing Group$380.48M0.26$50.08M$0.862.08

In the previous week, Quantasing Group had 2 more articles in the media than iHuman. MarketBeat recorded 2 mentions for Quantasing Group and 0 mentions for iHuman. Quantasing Group's average media sentiment score of 1.44 beat iHuman's score of 0.00 indicating that Quantasing Group is being referred to more favorably in the news media.

Company Overall Sentiment
iHuman Neutral
Quantasing Group Positive

Quantasing Group has a net margin of 31.15% compared to iHuman's net margin of 9.35%. iHuman's return on equity of 7.46% beat Quantasing Group's return on equity.

Company Net Margins Return on Equity Return on Assets
iHuman9.35% 7.46% 5.40%
Quantasing Group 31.15%2.48%1.45%

Quantasing Group has a consensus price target of $2.50, suggesting a potential upside of 39.66%. Given Quantasing Group's stronger consensus rating and higher possible upside, analysts clearly believe Quantasing Group is more favorable than iHuman.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
iHuman
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Quantasing Group
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

iHuman has a beta of 0.15, indicating that its share price is 85% less volatile than the broader market. Comparatively, Quantasing Group has a beta of -0.52, indicating that its share price is 152% less volatile than the broader market.

Summary

Quantasing Group beats iHuman on 8 of the 15 factors compared between the two stocks.

Get iHuman News Delivered to You Automatically

Sign up to receive the latest news and ratings for IH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IH vs. The Competition

MetriciHumanSCHOOLS IndustryDiscretionary SectorNYSE Exchange
Market Cap$72.57M$1.49B$7.24B$23.46B
Dividend YieldN/A2.43%3.03%4.02%
P/E Ratio7.5012.0820.2731.08
Price / Sales0.633.964.0519.77
Price / Cash4.9214.0213.4318.64
Price / Book0.512.453.774.77
Net Income$13.64M$78.99M$246.03M$1.06B
7 Day Performance-0.70%-0.74%0.40%-0.23%
1 Month Performance3.64%1.47%-1.06%-0.11%
1 Year Performance-36.38%-14.15%-1.79%16.46%

iHuman Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IH
iHuman
1.3219 of 5 stars
$1.43
+0.4%
N/A-37.8%$72.57M$115.40M7.501,120
JDZG
JIADE
0.7701 of 5 stars
$50.00
flat
N/AN/A$271.50M$3.67MN/AN/A
TONX
Verb Technology
1.0301 of 5 stars
$3.21
-5.3%
N/AN/A$180.90M$12.78MN/A170
NRDY
Nerdy
2.533 of 5 stars
$0.89
-2.6%
$1.00
+12.9%
-43.3%$167.49M$178.99MN/A700
HCMA
HCM Acquisition
1.6228 of 5 stars
$10.31
-0.2%
N/A+13.3%$145.73MN/AN/AN/A

Related Companies and Tools


This page (NYSE:IH) was last updated on 7/14/2026 by MarketBeat.com Staff.
From Our Partners